Arcus Biosciences share price logo

Arcus Biosciences

NYSE: RCUS

Mid Cap

$24.28

-0.46

(-1.86%)

as on

Arcus Biosciences Stock Performance

as on October 7, 2026 at 2:16 pm IST

  • Day's Low

    Day's High

    $23.96
    $24.84
    downward going graph

    1.32%

    Downside

    2.31%

    Upside

    downward going graph
  • 52 Week's Low

    52 Week's High

    $13.71
    $31.74
    downward going graph

    43.53%

    Downside

    30.70%

    Upside

    downward going graph

Arcus Biosciences share price movements today

Previous Close
$24.74
Open
$24.74
Volume
637.8K
Market Cap
$3.1B
Day's Low - High
$23.96 - $24.84
52 Week Low - High
$13.71 - $31.74

Arcus Biosciences Historical Returns

1 Month Return
-18.14 %
3 Month Return
-19.74 %
1 Year Return
+ 73.06 %
3 Year Return
+ 45.3 %
5 Year Return
-26.49 %

Arcus Biosciences Stock Fundamentals & Key Indicators

Check Arcus Biosciences market cap, PE, PB, PEG ratios, dividend yield, and other key fundamental indicators.

Market Cap

$3.1B

EPS (TTM)

-3.93

Dividend Yield

0.00%

Quarterly Earnings Growth YOY

0.00%

PE Ratio (TTM)

-6.3

Industry PE ratio

-11.23

PEG Ratio

0.30

EBITDA

-419.0M

Revenue (TTM)

117.0M

Profit Margin

94.02%

Return On Equity TTM

-87.98%

Arcus Biosciences vs Peer Comparison

Compare market cap, revenue, PE, and other key metrics of Arcus Biosciences with its industry peers.

Company
Analyst View
Market Cap
5 Years Return %PE RatioProfit Margin %Dividend Yield %
Buy$3.1B-26.49%-6.3094.02%0.00%
StrongBuy$44.5B617.67%-23.440.00%0.00%
Neutral$81.1B-39.40%-25.46-12.57%0.00%
StrongBuy$127.9B178.32%29.1486.04%0.00%
Buy$75.7B33.82%17.3584.86%0.51%

Stock Returns calculator for Arcus Biosciences Stock including INR - Dollar returns

The Arcus Biosciences stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

*Dollar Impact: The bonus return you make when the US Dollar rises against the Rupee; calculated on the full amount you walk away with, not just what you invested in.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

Arcus Biosciences investment value today

Current value as on today

₹1,88,075

Returns

₹88,075

(+88.08%)

Returns from Arcus Biosciences Stock

₹73,058 (+73.06%)

Dollar Impact

₹15,018 (+15.02%)

Analyst Recommendation on Arcus Biosciences Stock

Based on 7 analysts

BUY

57.14%

Buy

42.86%

Hold

0.00%

Sell

Based on 7 analysts, 57.14285714285714% of analysts recommend a 'BUY' rating for Arcus Biosciences. Average target price of $39.91

Arcus Biosciences Share Price Target

Get share price movements and forecasts by analysts on Arcus Biosciences.

What analysts predicted

39.16%UPSIDE

Target Price

$39.91

Current Price

$24.28

Analyzed by

7 Analysts

High

$46

Target

$39.91

Low

$23

Arcus Biosciences target price $39.91, a slight upside of 39.16% compared to current price of $24.28. According to 7 analysts rating.

Indian Investors' Interest in Arcus Biosciences Stock

Search interest for Arcus Biosciences Stock has decreased by -77% in the last 30 days, reflecting a downward trend in search activity.

Time period: to

Change:-77% versus previous 30 day period

Arcus Biosciences Quarterly Profit & Loss

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Total Revenue
145
39
48
26
28
160
26
33
17
41
Gross Profit
145
39
48
26
28
160
24
30
15
41
Operating Income
-16
-106
-105
-103
-122
-8
-142
-114
-134
-96
EBITDA
-
-91
-89
-89
-108
4
-130
-81
-123
-85
Interest Expense
1
-
1
2
1
2
3
14
3
3
Depreciation
3
2
2
3
3
2
2
3
2
3
Income Before Tax
-4
-93
-92
-94
-112
-8
-135
-98
-128
-91
Income Tax Expense
-
-
-
1
-
-
-
-
-
-
Net Income
-4
-93
-92
-94
-112
-8
-135
-98
-128
-91
Net Profit Margin
100.00%
100.00%
100.00%
100.00%
100.00%
100.00%
92.31%
90.91%
88.24%
100.00%

Arcus Biosciences Annual Profit & Loss

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Total Revenue
1
8
15
78
383
112
117
258
247
Gross Profit
1
8
15
78
383
112
117
258
237
Operating Income
-53
-54
-88
-124
54
-280
-340
-330
-386
EBITDA
-50
-51
-81
-120
59
-258
-291
-269
-335
Interest Expense
-
-
-
-
-
2
2
4
8
Depreciation
2
3
3
3
4
6
8
10
10
Income Before Tax
-53
-49
-84
-123
55
-266
-301
-283
-353
Income Tax Expense
-
-
-
-
2
1
6
1
-
Net Income
-53
-49
-84
-123
53
-267
-307
-283
-353
Net Profit Margin
100.00%
100.00%
100.00%
100.00%
100.00%
100.00%
100.00%
100.00%
95.95%

Arcus Biosciences Quarterly Cash Flow

All numbers in Millions USD

Mar 2024
Jun 2024
Sep 2024
Dec 2024
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Jun 2026
Net Income
-4
-93
-92
-94
-112
-
-135
-106
-128
-91
Operating Cash Flow
-2
-94
26
-100
-132
-133
-97
-120
-138
-119
Investing Cash Flow
-169
63
-29
51
32
137
79
-182
114
52
Financing Cash Flow
229
2
48
-2
142
52
8
286
3
16
Change in Cash
58
-29
45
-51
42
56
-10
-16
-21
-51

Arcus Biosciences Annual Cash Flow

All numbers in Millions USD

Dec 2017
Dec 2018
Dec 2019
Dec 2020
Dec 2021
Dec 2022
Dec 2023
Dec 2024
Dec 2025
Net Income
-53
-49
-84
-122
52
-267
-307
-283
-353
Operating Cash Flow
-25
-42
-73
111
-256
438
-306
-170
-482
Investing Cash Flow
-49
-113
59
-434
-3
-413
194
-84
66
Financing Cash Flow
107
129
1
438
237
33
33
277
488
Change in Cash
33
-27
-13
115
-25
58
-79
23
72

Global Institutional Holdings in Arcus Biosciences

Check out the Institutions with significant holdings in Arcus Biosciences.

Funds
Holdings
iShares
8.66%
Vanguard
5.37%
VANGUARD INDEX FUNDS
4.20%
SPDR
2.94%
VANGUARD SPECIALIZED FUNDS
2.71%

Insights on Arcus Biosciences

Insights help you understand the recent movement of the company's critical parameters, giving you an overall view of the company.

  • imgPOSITIVE IMPACT

    Price Rise

    img

    In the last 1 year, RCUS stock has moved up by 73.1%

  • imgPOSITIVE IMPACT

    Profit Spike

    img

    Netprofit is up for the last 2 quarters, -128.0M → -91.00M (in $), with an average increase of 40.7% per quarter

  • imgPOSITIVE IMPACT

    Revenue Rich

    img

    Revenue is up for the last 2 quarters, 17.0M → 40.99M (in $), with an average increase of 58.5% per quarter

  • imgNO EFFECT

    Against Peers

    img

    In the last 3 years, Revolution Medicines, Inc. Common Stock has given 80.5% return, outperforming this stock by 35.2%

  • imgNO EFFECT

    Against Peers

    img

    In the last 1 year, Moderna, Inc. Common Stock has given 585.7% return, outperforming this stock by 512.6%

About Arcus Biosciences

Arcus Biosciences, Inc., a clinical-stage biopharmaceutical company, develops and commercializes cancer therapies in the United States. The company’s development product portfolio includes Casdatifan, a HIF-2a inhibitor for the treatment of kidney cancer; Domvanalimab, an anti-TIGIT antibody, which is in Phase 2 and Phase 3 clinical trial for lung and gastrointestinal cancers; and Zimberelimab, an anti-PD-1 antibody. It also develops Quemliclustat, a small molecule inhibitor that targets the CD73 enzyme in the ATP-adenosine pathway, which is in phase 3 and phase 1/1b clinical trial for lung and pancreatic cancer. In addition, the company develops AB598, a CD39 antibody, which is in phase 1/1b clinical study for gastrointestinal cancer and AB801, an AXL inhibitor, which is in Phase 1b clinical trial for lung cancer. It has clinical collaboration with AstraZeneca for the Phase 3 PACIFIC-8 trial evaluating domvanalimab and durvalumab in Stage 3 NSCLC and for a Phase 1/1b study evaluating casdatifan and volrustomig in IO-naive patients with ccRCC and BVF Partners L.P. to support the discovery and development of compounds for the treatment of inflammatory diseases. Arcus Biosciences, Inc. was incorporated in 2015 and is based in Hayward, California.
OrganisationArcus Biosciences
Headquarters3928 Point Eden Way, Hayward, CA, 94545, US
IndustryBiotechnology
CEOTerry J. Rosen

Key Management of Arcus Biosciences

Name

Title

Dr. Terry J. Rosen Ph.D.

Co-Founder, Chairman & CEO

Mr. Robert C. Goeltz II

Principal Financial Officer & CFO

Dr. K. Christopher Garcia Ph.D.

Co-Founder & Member of Scientific Advisory Board

Mr. Alexander Azoy CPA

Chief Accounting Officer

Pia Eaves

Vice President of Investor Relations & Strategy

Holli Kolkey

Vice President of Corporate Communications

Dr. Juan Carlos Jaen Ph.D.

Co- Founder & President

Dr. Richard A. Markus M.D., Ph.D.

Chief Medical Officer

Dr. Jonathan Yingling Ph.D.

Chief Scientific Officer

Ms. Carolyn C. Tang J.D.

General Counsel & Corporate Secretary

FAQs

What is Arcus Biosciences share price today?

Arcus Biosciences share price today is $24.28 as on at the close of the market. Arcus Biosciences share today touched a day high of $24.84 and a low of $23.96.

What is the 52 week high and 52 week low for Arcus Biosciences share?

Arcus Biosciences share touched a 52 week high of $31.74 on and a 52 week low of $13.71 on . Arcus Biosciences stock price today i.e. is closed at $24.28,which is 23.49% down from its 52 week high and 77.10% up from its 52 week low.

What is Arcus Biosciences's market capitalisation today?

Arcus Biosciences market capitalisation is $0.00T as on .

How to invest in Arcus Biosciences Stock (RCUS) from India?

  1. Step 1: Open a free US stocks account on INDmoney App and transfer your Rupees into Dollars to your INDmoney US stocks account. For a step by step instruction, check How to Transfer Money to Your US Stocks Account .
  2. Step 2: Search for Arcus Biosciences on INDmoney app. Click on Buy button.

What is the minimum amount required to buy Arcus Biosciences Stock (RCUS) from India?

Indian investors can start investing in Arcus Biosciences (RCUS) shares with as little as ₹96.419998168945 or $1 (as of ) using the INDmoney app.
For example: If you want to invest $10 or ₹964.20 in Arcus Biosciences stock (as per the Rupee-Dollar exchange rate as on ). Based on Arcus Biosciences share’s latest price of $24.28 as on October 7, 2026 at 8:46 am IST, you will get 0.4119 shares of Arcus Biosciences. Learn more about fractional shares .

What are the returns that Arcus Biosciences has given to Indian investors in the last 5 years?

Arcus Biosciences stock has given -26.49% share price returns and 28.78% dollar appreciation to an Indian investor in the last 5 years.
Read more about How do Currency Exchange Rates impact your returns on US Stock Investments?